JANX vs POOL · $1.49B cap vs P/E 18, rev $5.31B
Janux Therapeutics Inc (JANX) versus Pool Corporation (POOL) — a side-by-side from cached financials, not a winner call.
Janux Therapeutics Inc (JANX) is a biotechnology company listed on US.
Pool Corporation (POOL) is a industrial distribution company listed on NASDAQ.
JANX does not have a complete income-statement cache yet.
Latest reported POOL revenue for 2024-12-31 was $5.31B. Net income was $434.3M. Revenue was up 429.5% from 2023-12-31 to 2024-12-31. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
JANX currently screens at market cap $1.49B. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
Not investment advice. Open the JANX and POOL stock pages for the full models.
Not investment advice.